These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Synergistic effect of azacitidine with homoharringtonine by activating the c-MYC/DDIT3/PUMA axis in acute myeloid leukemia]. Author: Li J, Huang YQ, Zi J, Song CH, Ge Z. Journal: Zhonghua Xue Ye Xue Za Zhi; 2023 Dec 14; 44(12):1001-1009. PubMed ID: 38503523. Abstract: Objective: This study aimed to explore the synergistic effect and underlying mechanism of azacitidine (AZA) in combination with homoharringtonine (HHT) in acute myeloid leukemia (AML) . Methods: The synergistic effects of AZA and HHT were examined by cell proliferation, apoptosis, and colony formation assays. The synergistic effects were calculated using the combination index (CI) , and the underlying mechanisms were explored using RNA sequencing, pathway inhibitors, and gene knockdown approaches. Results: Compared with the single-drug controls, AZA and HHT combination significantly induced cell proliferation arrest and showed a synergistic effect with CI < 0.9 in AML cells. In the combination group versus the single-drug controls, colony formation was significantly decreased, whereas apoptosis was significantly increased in U937 (P<0.001) and MV4-11 (P<0.001) cells. AZA and HHT combination activated the integrated stress response (ISR) signaling pathway and induced DDIT3-PUMA-dependent apoptosis in cells. Furthermore, it remarkably downregulated the expression of c-MYC. The combination also activated c-MYC/DDIT3/PUMA-mediated ISR signaling to induce synergy on apoptosis. The synergy of AZA+HHT on apoptosis was induced by activating c-MYC/DDIT3/PUMA-mediated ISR signaling. Conclusion: The combination of AZA and HHT exerts synergistic anti-AML effects by inhibiting cellular proliferation and promoting apoptosis through activation of the ISR signaling pathway via the c-MYC/DDIT3/PUMA axis. 目的: 探索阿扎胞苷(AZA)联合高三尖杉酯碱(HHT)治疗急性髓系白血病(AML)的协同效应及其分子机制。 方法: 采用细胞增殖、凋亡和克隆形成实验研究AZA联合HHT在AML中协同效应并计算两药协同效应指数(CI),通过转录组测序、通路抑制剂和基因敲降等方法,探索两药的协同机制。 结果: 与单药相比,AZA+ HHT可显著抑制AML细胞增殖,并具有显著的协同效应(U937、MV4-11和KG-1细胞中CI值均小于0.9);AZA+HHT能显著抑制U937(P<0.001)和MV4-11(P<0.001)细胞的克隆形成,并显著促进U937(P<0.001)和MV4-11(P<0.001)细胞凋亡。AZA联合HHT通过激活整合应激反应(ISR)信号通路介导DDIT3-PUMA依赖的AML细胞凋亡。AZA联合HHT可明显下调c-MYC蛋白,通过激活ISR信号通路,调控c-MYC/DDIT3/PUMA轴,促进细胞凋亡发挥协同抗AML作用。 结论: AZA联合HHT通过激活ISR信号通路,调控c-MYC/DDIT3/PUMA轴,抑制细胞增殖和促进细胞凋亡,发挥协同抗AML作用。.[Abstract] [Full Text] [Related] [New Search]